Anniina Snellman
Docent
aepakk@utu.fi +358 0 231 3872 Kiinamyllynkatu 4-8 Turku ORCID identifier: https://orcid.org/http://orcid.org/0000-0001-6191-0954 |
Publications
- Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burden (2023)
- Alzheimer's and Dementia
(A1 Refereed original research article in a scientific journal) - ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease - Study Protocol and Baseline Characteristics(S)-[18F]THK5117 brain uptake is associated with Aβ plaques and MAO-B enzyme in a mouse model of Alzheimer's disease (2022)
- Frontiers in NeurologyNeuropharmacology
(A1 Refereed original research article in a scientific journal) - (2022)
- PsychoneuroendocrinologyBrain
(A1 Refereed original research article in a scientific journal) - CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design (2022)
- Alzheimer's and Dementia
(A1 Refereed original research article in a scientific journal) - Neuropsykologiset tehtäväsarjat Alzheimerin taudin prekliinisen vaiheen hienoisen kognitiivisen heikentymisen havaitsemisessa (2022)
- DuodecimJournal of Internal Medicine
(A2 Refereed review article in a scientific journal ) - N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseasesDiagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative (2022)
- BrainMolecular Psychiatry
(A1 Refereed original research article in a scientific journal) - Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative (2021)
- Alzheimer's Research and Therapy
(A1 Refereed original research article in a scientific journal) - Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy (2021)
- Neurology
(A1 Refereed original research article in a scientific journal) - Effects of pre-analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration (2021)
- Alzheimer's & dementia: diagnosis, assessment & disease monitoring
(A1 Refereed original research article in a scientific journal) - Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease (2021)
- JAMA Neurology
(A1 Refereed original research article in a scientific journal) - Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals (2021)
- Brain Communications
(A1 Refereed original research article in a scientific journal) - Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study (2021)
- Theranostics
(A1 Refereed original research article in a scientific journal) - P-tau235: a novel biomarker for staging preclinical Alzheimer's disease (2021)
- Embo molecular medicine
(A1 Refereed original research article in a scientific journal) - (2021)
(A1 Refereed original research article in a scientific journal) - Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum (2021)
(A1 Refereed original research article in a scientific journal) - Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease (2021)
(A2 Refereed review article in a scientific journal ) - (2020)
(A1 Refereed original research article in a scientific journal) - Effect of genotype and age on cerebral [F-18]FDG uptake varies between transgenic APP(swe)-PS1(dE9) and Tg2576 mouse models of Alzheimer's disease (2019)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer's Disease (2018)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - [F-18]FMPEP-d(2) PET imaging shows age- and genotype-dependent impairments in the availability of cannabinoid receptor 1 in a mouse model of Alzheimer's disease (2018)
- Neurobiology of Aging
(A1 Refereed original research article in a scientific journal)



